Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]
Nano Pharmaceuticals Labs Partners with PLT Health Solutions to Expand its zümXR Targeted Release Ingredients Globally
PLT Health Solutions announced that it has partnered with Nano Pharmaceuticals Labs to market its […]
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics
Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on […]
Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. To Board of Directors
Areteia Therapeutics, today announced the appointment of Elyse Stock to the Areteia Board of Directors, […]
Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients
Tubulis and Bristol Myers Squibb today announced that they have entered into a strategic license […]
Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership
Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio […]
Cardurion Pharmaceuticals Further Bolsters Leadership Team with Appointment of Stephen Migausky as General Counsel
Cardurion Pharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation […]
Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat" Autoimmune Diseases
Biotechnology company Maxion Therapeutics has announced it has been awarded a prestigious GBP £2 million […]
Engimmune Therapeutics Appoints Dr. Lars Nieba as Chief Executive Officer
Engimmune Therapeutics, a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today announces the […]
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more